Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Blast Crisis × Vemurafenib × Clear all

Sponsor

Conditions

Melanoma 29 Neoplasms 7 Neoplasm Metastasis 3 Skin Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Lymphoma, Non-Hodgkin 1 Leukemia, Hairy Cell 1 Histiocytosis, Langerhans-Cell 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Glioma 1 Ependymoma 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

fludarabine phosphate 23 Cyclophosphamide 22 Busulfan 19 Whole-Body Irradiation 18 Peripheral Blood Stem Cell Transplantation 18 Mycophenolic Acid 17 Tacrolimus 13 Cyclosporine 12 Antilymphocyte Serum 12 Methotrexate 10 Melphalan 9 Filgrastim 8 Cytarabine 8 Etoposide 7 Cord Blood Stem Cell Transplantation 7 fludarabine 6 Methylprednisolone 6 Granulocyte Colony-Stimulating Factor 5 thymoglobulin 4 Thiotepa 4 Sirolimus 4 Rituximab 4 Radiotherapy 4 Imatinib Mesylate 4 Flow Cytometry 4 Dexamethasone 4 Cyclosporins 4 Calcium Dobesilate 4 dexamethasone acetate 3 dexamethasone 21-phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡